Nisa Investment Advisors’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21K Buy
394
+74
+23% +$321 ﹤0.01% 2713
2025
Q4
$1.14K Sell
320
-801
-71% -$4.91K ﹤0.01% 2697
2025
Q3
$9.98K Hold
1,121
﹤0.01% 2281
2025
Q2
$10.3K Sell
1,121
-1,002
-47% -$8.55K ﹤0.01% 2246
2025
Q1
$18.2K Sell
2,123
-138
-6% -$1.3K ﹤0.01% 1921
2024
Q4
$24.3K Buy
2,261
+434
+24% +$3.34K ﹤0.01% 1880
2024
Q3
$10.4K Hold
1,827
﹤0.01% 2090
2024
Q2
$7.71K Buy
1,827
+192
+12% +$777 ﹤0.01% 2210
2024
Q1
$8.32K Buy
1,635
+85
+5% +$478 ﹤0.01% 2067
2023
Q4
$14.4K Sell
1,550
-24
-2% -$165 ﹤0.01% 1955
2023
Q3
$10.3K Sell
1,574
-16
-1% -$127 ﹤0.01% 2171
2023
Q2
$12.9K Sell
1,590
-710
-31% -$6.08K ﹤0.01% 2212
2023
Q1
$20K Buy
2,300
+1,600
+229% +$16K ﹤0.01% 2005
2022
Q4
$6K Sell
700
-60
-8% -$641 ﹤0.01% 2272
2022
Q3
$9K Buy
760
+60
+9% +$633 ﹤0.01% 2201
2022
Q2
$7K Hold
700
﹤0.01% 2231
2022
Q1
$9K Buy
+700
New +$8.61K ﹤0.01% 2217
2021
Q4
Sell
-990
Closed -$18 2214
2021
Q3
$18 Hold
990
﹤0.01% 2111
2021
Q2
$23 Buy
+990
New +$14.7K ﹤0.01% 2107

Other funds holding AVXL

Nisa Investment Advisors's AVXL Position: Q1 2026 in Review

Nisa Investment Advisors increased its Anavex Life Sciences (AVXL) stake by 23% in Q1 2026, buying an estimated $321 and bringing the position to 394 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2713.

Nisa Investment Advisors first reported a position in AVXL in Q2 2021 and has held it in 19 quarters since. The position peaked at $24.3K in Q4 2024. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Nisa Investment Advisors held 394 shares of Anavex Life Sciences worth $1.21K as of Q1 2026.
  • Nisa Investment Advisors bought 74 Anavex Life Sciences shares in Q1 2026, an estimated $321.
  • Anavex Life Sciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2713 holding.
  • Nisa Investment Advisors first reported a position in Anavex Life Sciences in Q2 2021 and has held it in 19 quarters since.
  • Nisa Investment Advisors's Anavex Life Sciences position peaked at $24.3K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.